TRKNF yields 250.41% · JNJ yields 2.13%● Live data
📍 TRKNF pulled ahead of the other in Year 1
Combined, TRKNF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TRKNF + JNJ for your $10,000?
Türk Telekomünikasyon Anonim Sirketi, together with its subsidiaries, provides integrated telecommunication services in Turkey. The company operates in two segments, Fixed Line and Mobile. It offers mobile, internet, phone and TV products and services under Türk Telekom brand name. The company also provides PSTN and wholesale broadband services; retail internet services, IPTV, satellite TV, Web TV, mobile TV, and smart TV services; IT solutions; convergence technologies; online education software; project development and corporate venture capital services; and wholesale data and capacity services. In addition, it offers TV Broadcasting and VOD services; telecommunications devices sales; payment and e-money services; and web portal and computer programming services. Further, the company provides call center, electric supply and sales, facilities support, and counselling services. As of December 31, 2021, it had 16.9 million fixed access lines; 14.3 million broadband; 2.9 million TV; and 24.0 million mobile subscribers in 81 cities. The company was founded in 1840 and is headquartered in Ankara, Turkey. Türk Telekomünikasyon Anonim Sirketi is a subsidiary of LYY Telekomünikasyon A.S.
Full TRKNF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.